Frequent mutation of the FOXA1 untranslated region in prostate cancer

被引:21
|
作者
Annala, Matti [1 ,2 ,3 ]
Taavitsainen, Sinja [1 ,2 ]
Vandekerkhove, Gillian [3 ]
Bacon, Jack V. W. [3 ]
Beja, Kevin [3 ]
Chi, Kim N. [3 ,4 ]
Nykter, Matti [1 ,2 ]
Wyatt, Alexander W. [3 ]
机构
[1] Univ Tampere, Fac Med & Life Sci, FI-33520 Tampere, Finland
[2] Univ Tampere, Biomeditech Inst, FI-33520 Tampere, Finland
[3] Univ British Columbia, Vancouver Prostate Ctr, Dept Urol Sci, Vancouver, BC V6H 3Z6, Canada
[4] British Columbia Canc Agcy, Dept Med Oncol, Vancouver, BC V5Z 1G1, Canada
基金
芬兰科学院; 加拿大健康研究院;
关键词
SOMATIC MUTATIONS; RECURRENT; GENOMICS; LANDSCAPE; REVEALS; GENES;
D O I
10.1038/s42003-018-0128-1
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Prostate cancer has a low somatic mutation rate but non-coding regions remain under-explored. We sequenced the untranslated regions (UTRs) of 72 established driver genes in 428 patients with metastatic prostate cancer and identified FOXA1 3'-UTR mutations in 12% of patients. The mutations were predominantly insertions or deletions, covered the entire UTR without motif enrichment, and were not detected in other cancers. FOXA1 lies in head-on orientation with the androgen-regulated non-coding gene AL121790.1, resulting in strong prostate lineage-specific bidirectional transcription across the FOXA1 3'-UTR. This suggests transcriptional activity as a cause for the localized hypermutation. The indel-dominant pattern of somatic mutation extends into the FOXA1 coding region, where it is shaped by clonal selection to yield a cluster of non-frameshift indels inside the forkhead domain. Somatic FOXA1 3'-UTR mutations may prove useful for diagnostic and screening approaches, given their high frequency and lineage specificity.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Frequent mutation of the FOXA1 untranslated region in prostate cancer
    Matti Annala
    Sinja Taavitsainen
    Gillian Vandekerkhove
    Jack V. W. Bacon
    Kevin Beja
    Kim N. Chi
    Matti Nykter
    Alexander W. Wyatt
    [J]. Communications Biology, 1
  • [2] FOXA1 in prostate cancer
    Dong, Hui-Yu
    Ding, Lei
    Zhou, Tian-Ren
    Yan, Tao
    Li, Jie
    Liang, Chao
    [J]. ASIAN JOURNAL OF ANDROLOGY, 2023, 25 (03) : 287 - 295
  • [3] The Sly Oncogene: FOXA1 Mutations in Prostate Cancer
    Shah, Neel
    Brown, Myles
    [J]. CANCER CELL, 2019, 36 (02) : 119 - 121
  • [4] FOXA1 inhibits prostate cancer neuroendocrine differentiation
    J Kim
    H Jin
    J C Zhao
    Y A Yang
    Y Li
    X Yang
    X Dong
    J Yu
    [J]. Oncogene, 2017, 36 : 4072 - 4080
  • [5] FOXA1 regulates alternative splicing in prostate cancer
    Del Giudice, Marco
    Foster, John G.
    Peirone, Serena
    Rissone, Alberto
    Caizzi, Livia
    Gaudino, Federica
    Parlato, Caterina
    Anselmi, Francesca
    Arkell, Rebecca
    Guarrera, Simonetta
    Oliviero, Salvatore
    Basso, Giuseppe
    Rajan, Prabhakar
    Cereda, Matteo
    [J]. CELL REPORTS, 2022, 40 (13):
  • [6] Different FOXA1 classes drive prostate cancer
    Stone L.
    [J]. Nature Reviews Urology, 2019, 16 (9) : 508 - 508
  • [7] FOXA1 inhibits prostate cancer neuroendocrine differentiation
    Kim, J.
    Jin, H.
    Zhao, J. C.
    Yang, Y. A.
    Li, Y.
    Yang, X.
    Dong, X.
    Yu, J.
    [J]. ONCOGENE, 2017, 36 (28) : 4072 - 4080
  • [8] Targeting LSD1 and FOXA1 in prostate cancer
    Omarjee, Soleilmane
    Carroll, Jason S.
    [J]. NATURE GENETICS, 2020, 52 (10) : 1002 - 1003
  • [9] Targeting LSD1 and FOXA1 in prostate cancer
    Soleilmane Omarjee
    Jason S. Carroll
    [J]. Nature Genetics, 2020, 52 : 1002 - 1003
  • [10] FOXA1 Expression Predicts Likelihood of Metastasis in Prostate Cancer
    Jain, R. K.
    Mehta, R.
    Idrees, M. T.
    Nakshatri, H.
    Badve, S.
    [J]. LABORATORY INVESTIGATION, 2010, 90 : 197A - 198A